Related Experiment Video
Updated: Feb 20, 2026

10:36
Rare Event Detection Using Error-corrected DNA and RNA Sequencing
Published on: August 3, 2018
12.6K
High-frequency, low-coverage "false positives" mutations may be true in GS Junior sequencing studies.
1Department of Pediatrics, the First Hospital of China Medical University, Shenyang, 110001, China. sizhewujiu@163.com.
Scientific Reports
|October 25, 2017
Summary
GS Junior sequencing can produce false positives. Sanger sequencing validation is crucial for mutations with borderline characteristics, especially those over 30% frequency, to ensure accurate results.
Area of Science:
- Genomics
- Molecular Biology
- Bioinformatics
Background:
- The GS Junior sequencer offers streamlined library preparation and data processing.
- Pyrosequencing errors can introduce biases during library construction and emulsion PCR.
- Distinguishing true positives from false positives among low-frequency or low-coverage mutations is challenging.
Purpose of the Study:
- To enhance the accuracy of identifying true positive mutations among those with borderline false-positive characteristics detected by GS Junior sequencing.
- To establish reliable criteria for validating low-frequency and low-coverage variants.
Main Methods:
- Sanger sequencing was employed to validate mutations identified by GS Junior sequencing.
- Mutations were categorized into two groups based on coverage (<20-fold) and frequency (>30%) or vice versa.
- Statistical analysis was performed to compare false-positive rates between groups.
Main Results:
- Mutations with borderline characteristics were evaluated using Sanger sequencing.
- Group A (coverage <20-fold, frequency >30%): 2 of 10 mutations were unconfirmed; 2 heterozygous alleles were confirmed.
- Group B (coverage >20-fold, frequency <30%): None of the 16 mutations were confirmed.
- Significantly different false-positive prevalences were observed between the two groups (p=0.001).
Conclusions:
- Mutations detected at frequencies below 30% can be confidently classified as false positives.
- Mutations with frequencies over 30%, even with coverage below 20-fold, require verification via Sanger sequencing for accurate identification.

